[1]
Ross, L.L., Robinson, M.D., Carosi, G., Lazzarin, A., Stellbrink, H.-J., Moyle, G., Givens, N. and Nichols, W.G. 2011. Impact of HIV subtype on response and resistance in antiretroviral-naïve adults comparing treatment with once daily versus twice daily ritonavir boosted fosamprenavir in combination with Abacavir/Lamivudine. Drugs and Therapy Studies. 2, 1 (Dec. 2011), e1. DOI:https://doi.org/10.4081/dts.2012.e1.